1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Dendrímeros para aplicaciones biomédicas

Dendrímeros para aplicaciones biomédicas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Bouaouz S, Chavez M, Peña González CE, Rojas D, Escarpa A, Ortega P, Javier de la Mata F.

    Enhancing Polyphenol Delivery and Efficacy Using Functionalized Gold Nanoparticles: Antioxidant and Antibacterial Properties.

    BIOINORG CHEM APPL . 2025: 3836765-3836765.

    [doi:10.1155/bca/3836765]

  • Wegierek-Ciuk A, Baczewska M, Galczynska K, Ortega P, de la Mata FJ, Kujawinska M, Arabski M.

    Enhanced methodology for analysis cytotoxicity of ruthenium dendrimers.

    Methods . 238: 1-10.

    [doi:10.1016/j.ymeth.2025.02.009]

  • Garrosa-Miró Y, Muñoz-Moreno L, D'Errico G, Tancredi M, Carmena MJ, Ottaviani MF, Ortega P, de la Mata J.

    Ruthenium(II) and copper(II) polyamine complexes as promising antitumor agents: synthesis, characterization, and biological evaluation.

    DALTON TRANSACTIONS . 54(18): 7506-7521.

    [doi:10.1039/d4dt03377a]

  • Lasak M, Lysek-Gladysinska M, Lach K, Nirwan VP, Kuc-Ciepluch D, Sanchez-Nieves J, de la Mata FJ, Fahmi A, Ciepluch K.

    Electrospun Nanofibers for the Delivery of Endolysin/Dendronized Ag-NPs Complex Against Pseudomonas aeruginosa.

    Nanotechnology, Science and Applications . 18: 57-70.

    [doi:10.2147/NSA.S498942]

  • Gallardo LO, Aiger Vallés M, Cativiela-Campos B, Domingo-Valero L, Barrasa Á, Alique M, López-Granero C.

    Psychological repercussions of PM air pollution in human aging: a comprehensive review of urban and rural environments.

    FRONTIERS IN PHARMACOLOGY . 16: 1517090-1517090.

    [doi:10.3389/fphar.2025.1517090]

  • Valera-Arévalo G, Rodríguez-San Pedro MDM, Caro PJ, Cabanillas V, Ortiz-Diaz MG, Figuer A, Yuste C, Ramírez R, Alique M, Morales E, Guerra-Pérez N, Carracedo J.

    Oxidative Score and Microvesicle Profile Suggest Cardiovascular Risk in Chronic Kidney Disease.

    ANTIOXIDANTS . 14(2): .

    [doi:10.3390/antiox14020178]

  • Barrios O, Inclán C, Herrera P, Bort A, Martín A, Cano J, Díaz-Laviada I, Gómez R.

    Ruthenium(II) complexes containing PEGylated N-heterocyclic carbene ligands for tunning biocompatibility in the fight against cancer.

    JOURNAL OF INORGANIC BIOCHEMISTRY . 262: 112765-112765.

    [doi:10.1016/j.jinorgbio.2024.112765]

  • García-Soriano JC, de Lucio H, Elvira-Blázquez D, Alcón-Calderón M, Sanz Del Olmo N, Sánchez-Murcia PA, Ortega P, de la Mata FJ, Jiménez-Ruiz A.

    The repertoire of iron superoxide dismutases from Leishmania infantum as targets in the search for therapeutic agents against leishmaniasis.

    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY . 39(1): 2377586-2377586.

    [doi:10.1080/14756366.2024.2377586]

  • Verdú-Expósito C, Martín-Pérez T, Pérez-Serrano J, Sanchez-Nieves J, de la Mata FJ, Heredero-Bermejo I.

    Amoebicidal and cysticidal in vitro activity of cationic dendritic molecules against Acanthamoeba polyphaga and Acanthamoeba griffini.

    PARASITOLOGY RESEARCH . 123(12): 401-401.

    [doi:10.1007/s00436-024-08413-9]

  • Grodzicka M, Michlewska S, Buczkowski A, Ortega P, de la Mata FJ, Bryszewska M, Ionov M.

    Effect of polyphenolic dendrimers on biological and artificial lipid membranes.

    CHEMISTRY AND PHYSICS OF LIPIDS . 265: 105444-105444.

    [doi:10.1016/j.chemphyslip.2024.105444]

  • Okla E, Michlewska S, Buczkowski A, Zawadzki S, Milowska K, Sánchez-Nieves J, Gómez R, de la Mata FJ, Bryszewska M, Blasiak J, Ionov M.

    Pegylated gold nanoparticles interact with lipid bilayer and human serum albumin and transferrin.

    SCIENTIFIC REPORTS . 14(1): 24408-24408.

    [doi:10.1038/s41598-024-74898-0]

  • Madrid L, Pinto-Díez C, Muñoz-Moreno L, García-Hernández M, González VM, Mata J, Martin ME, Ortega P.

    Cationic Carbosilane Dendrimers for Apmnkq2 Aptamer Transfection in Breast Cancer: An Alternative to Traditional Transfectants.

    MACROMOLECULAR BIOSCIENCE . : .

    [doi:10.1002/mabi.202400327]

  • Lach K, Skrzyniarz K, Takvor-Mena S, Lysek-Gladysinska M, Furmanczyk P, Barrios-Gumiel O, Sanchez-Nieves J, Ciepluch K.

    Endolysin CHAP domain-carbosilane metallodendrimer complexes with triple action on Gram-negative bacteria: Membrane destabilization, reactive oxygen species production and peptidoglycan degradation.

    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES . 278(Pt 3): 134634-134634.

    [doi:10.1016/j.ijbiomac.2024.134634]

  • Figuer A, Santos FM, Ciordia S, Valera G, Martín-Jouve B, Hernández-Fonseca JP, Bodega G, Ceprián N, Ramírez R, Carracedo J, Alique M.

    Proteomic analysis of endothelial cells and extracellular vesicles in response to indoxyl sulfate: Mechanisms of endothelial dysfunction in chronic kidney disease.

    LIFE SCIENCES . 351: 122810-122810.

    [doi:10.1016/j.lfs.2024.122810]

  • Huerta MÁ, Cisneros E, Alique M, Roza C.

    Strategies for Measuring Non-Evoked Pain in Preclinical Models of Neuropathic Pain: Systematic Review.

    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS . 163: 105761-105761. Nº de citas: 2

    [doi:10.1016/j.neubiorev.2024.105761]

  • Skrzyniarz K, Takvor-Mena S, Lach K, Lysek-Gladysinska M, Barrios-Gumiel Ó, Cano J, Ciepluch K.

    Molecular mechanism of action of imidazolium carbosilane dendrimers on the outer bacterial membrane - From membrane damage to permeability to antimicrobial endolysin.

    JOURNAL OF COLLOID AND INTERFACE SCIENCE . 665: 814-824. Nº de citas: 3

    [doi:10.1016/j.jcis.2024.03.130]

  • Bellavita R, Esposito S, Braccia S, Madrid L, Ortega P, D'Auria G, Zarrilli F, Amato F, Galdiero S, de la Mata J, Falcigno L, Falanga A.

    Targetable domains for the design of peptide-dendrimer inhibitors of SARS-CoV-2.

    INTERNATIONAL JOURNAL OF PHARMACEUTICS . 661: 124389-124389.

    [doi:10.1016/j.ijpharm.2024.124389]

  • Grodzicka M, Michlewska S, Blasiak J, Ortega P, de la Mata FJ, Bryszewska M, Ionov M.

    Polyphenolic dendrimers as carriers of anticancer siRNA.

    INTERNATIONAL JOURNAL OF PHARMACEUTICS . 658: 124199-124199.

    [doi:10.1016/j.ijpharm.2024.124199]